Cargando…
Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease
Phenotypic screening has yielded small-molecule inhibitors of prion replication that are effective in vivo against certain prion strains but not others. Here, we sought to test the small molecule anle138b in multiple mouse models of prion disease. In mice inoculated with the RML strain of prions, an...
Autores principales: | Vallabh, Sonia M., Zou, Dan, Pitstick, Rose, O’Moore, Jill, Peters, Janet, Silvius, Derek, Kriz, Jasna, Jackson, Walker S., Carlson, George A., Minikel, Eric Vallabh, Cabin, Deborah E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973041/ https://www.ncbi.nlm.nih.gov/pubmed/36651748 http://dx.doi.org/10.1128/jvi.01672-22 |
Ejemplares similares
-
Deer Prion Proteins Modulate the Emergence and Adaptation of Chronic Wasting Disease Strains
por: Duque Velásquez, Camilo, et al.
Publicado: (2015) -
Oral Prion Neuroinvasion Occurs Independently of PrP(C) Expression in the Gut Epithelium
por: Marshall, Alison, et al.
Publicado: (2018) -
Oral Prion Disease Pathogenesis Is Impeded in the Specific Absence of CXCR5-Expressing Dendritic Cells
por: Bradford, Barry M., et al.
Publicado: (2017) -
The Gut-Associated Lymphoid Tissues in the Small Intestine, Not the Large Intestine, Play a Major Role in Oral Prion Disease Pathogenesis
por: Donaldson, David S., et al.
Publicado: (2015) -
Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
por: Minikel, Eric Vallabh, et al.
Publicado: (2020)